Jennifer L Moss1, Schatzi H McCarthy1, Melissa B Gilkey2, Noel T Brewer3. 1. Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. 2. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 3. Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ntb@unc.edu.
Abstract
OBJECTIVE: The Carolina Framework for Cervical Cancer Prevention describes 4 main causes of cervical cancer incidence: human papillomavirus (HPV) infection, lack of screening, screening errors, and not receiving follow-up care. We present 2 applications of the Carolina Framework in which we identify high-need counties in North Carolina and generate recommendations for improving prevention efforts. METHODS: We created a cervical cancer prevention need index (CCPNI) that ranked counties on cervical cancer mortality, HPV vaccine initiation and completion, Pap smear screening, and provision of Pap tests to rarely- or never-screened women. In addition, we conducted in-depth interviews with 19 key informants from programs and agencies involved in cervical cancer prevention in North Carolina. RESULTS: North Carolina's 100 counties varied widely on individual CCPNI components, including annual cervical cancer mortality (median 2.7/100,000 women; range 0.0-8.0), adolescent girls' HPV vaccine initiation (median 42%; range 15%-62%), and Pap testing in the previous 3 years among Medicaid-insured adult women (median 59%; range 40%-83%). Counties with the greatest prevention needs formed 2 distinct clusters in the northeast and south-central regions of the state. Interviews generated 9 recommendations to improve cervical cancer prevention in North Carolina, identifying applications to specific programs and policies in the state. CONCLUSIONS: This study found striking geographic disparities in cervical cancer prevention need in North Carolina. Future prevention efforts in the state should prioritize high-need regions as well as recommended strategies and applications in existing programs. Other states can use the Carolina Framework to increase the impact of their cervical cancer prevention efforts.
OBJECTIVE: The Carolina Framework for Cervical Cancer Prevention describes 4 main causes of cervical cancer incidence: human papillomavirus (HPV) infection, lack of screening, screening errors, and not receiving follow-up care. We present 2 applications of the Carolina Framework in which we identify high-need counties in North Carolina and generate recommendations for improving prevention efforts. METHODS: We created a cervical cancer prevention need index (CCPNI) that ranked counties on cervical cancer mortality, HPV vaccine initiation and completion, Pap smear screening, and provision of Pap tests to rarely- or never-screened women. In addition, we conducted in-depth interviews with 19 key informants from programs and agencies involved in cervical cancer prevention in North Carolina. RESULTS: North Carolina's 100 counties varied widely on individual CCPNI components, including annual cervical cancer mortality (median 2.7/100,000 women; range 0.0-8.0), adolescent girls' HPV vaccine initiation (median 42%; range 15%-62%), and Pap testing in the previous 3 years among Medicaid-insured adult women (median 59%; range 40%-83%). Counties with the greatest prevention needs formed 2 distinct clusters in the northeast and south-central regions of the state. Interviews generated 9 recommendations to improve cervical cancer prevention in North Carolina, identifying applications to specific programs and policies in the state. CONCLUSIONS: This study found striking geographic disparities in cervical cancer prevention need in North Carolina. Future prevention efforts in the state should prioritize high-need regions as well as recommended strategies and applications in existing programs. Other states can use the Carolina Framework to increase the impact of their cervical cancer prevention efforts.
Authors: Christine M Pierce Campbell; Lynette J Menezes; Electra D Paskett; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-03 Impact factor: 4.254
Authors: Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley Journal: CA Cancer J Clin Date: 2010 Mar-Apr Impact factor: 508.702
Authors: J Hsia; E Kemper; C Kiefe; J Zapka; S Sofaer; M Pettinger; D Bowen; M Limacher; L Lillington; E Mason Journal: Prev Med Date: 2000-09 Impact factor: 4.018
Authors: Madeleine Courtney-Brooks; Elizabeth B Pelkofski; Carolyn L Engelhard; Linda R Duska Journal: Gynecol Oncol Date: 2013-05-03 Impact factor: 5.482
Authors: Richard Musto; Jodi E Siever; J Cyne Johnston; Judy Seidel; M Sarah Rose; Deborah A McNeil Journal: BMC Public Health Date: 2013-07-09 Impact factor: 3.295
Authors: Cary Suzanne Lea; Carolina Perez-Heydrich; Andrea C Des Marais; Alice R Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith Journal: J Womens Health (Larchmt) Date: 2019-03-15 Impact factor: 2.681
Authors: Parth D Shah; Justin G Trogdon; Shelley D Golden; Carol E Golin; Macary Weck Marciniak; Noel T Brewer Journal: Milbank Q Date: 2018-09 Impact factor: 4.911
Authors: Jennifer L Moss; Ming Wang; Menglu Liang; Alain Kameni; Kelsey C Stoltzfus; Tracy Onega Journal: Cancer Epidemiol Date: 2021-09-21 Impact factor: 2.984